First Sentier group raises stake in Australian Clinical Labs

First Sentier Group Limited, along with its related bodies corporate and associates, has become a more prominent substantial holder in Australian Clinical Labs Ltd. The group's voting power increased from a previous 7.13% to 8.74% as of October 15, 2025. This change represents an increase in votes from 14,007,561 to 17,120,818 fully paid ordinary shares.

The change in relevant interests primarily stems from various purchase transactions of fully paid ordinary shares by First Sentier Investors RQI Pty Ltd between August 28, 2025, and October 15, 2025. These transactions involved numerous purchases, with significant amounts including AUD 459,310.28 for 168,740 shares on September 1, 2025, AUD 454,733.78 for 180,859 shares on October 6, 2025, and AUD 268,928.67 for 109,414 shares on October 13, 2025.

Additionally, Mitsubishi UFJ Financial Group Inc. holds a relevant interest in 2,944,229 fully paid ordinary shares of Australian Clinical Labs Ltd, contributing to the overall voting power. First Sentier Group Limited's ultimate parent, Mitsubishi UFJ Financial Group, Inc., also informed of its voting power as of October 15, 2025.